Acceptability and Feasibility of a Stress Prevention Program Based on Meditation and Acceptance and Commitment Therapy for Staff at a Cancer Center

NCT ID: NCT06903104

Last Updated: 2025-12-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-13

Study Completion Date

2025-09-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The MAEva program seems to meet the challenges of implementing meditation for cancer care workers. As part of our Quality of Life and Working Conditions initiative, the investigator decided to offer it to staff at our Cancer Center. The MAEva program is delivered in a closed format: participants commit to following, as far as possible, the three sessions of the program - one session per week for 3 weeks. During the sessions, it will be proposed to train meditative practices and three different themes will be addressed (one theme per session): Meditation, Acceptance and Commitment to values.

Before and after the program, participants will complete a quality of life evaluation, a perceived stress scale, and a questionnaire to assess psychological flexibility.

At the end of the program, each participant will be asked to complete a satisfaction questionnaire and a semi-directive interview, by videoconference, or by telephone in the event of digital impossibility with voice recording, to enable a qualitative analysis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Employees at a Hospital

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

MAEva program Quality of life Mindfulness Workplace Caregivers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MAEva program is delivered in a closed format

MAEva program is delivered in a closed format. One session per week for 3 weeks.

Group Type EXPERIMENTAL

Mindfulness closed program

Intervention Type OTHER

MAEva program will be proposed with meditative practices and three different themes will be addressed (one theme per session): Meditation, Acceptance and Commitment to values.

Quality of life evaluation

Intervention Type DIAGNOSTIC_TEST

The assessment will be carried out at inclusion and after completion of the program.

Perceived Stress Scale

Intervention Type DIAGNOSTIC_TEST

The assessment will be carried out at inclusion and after completion of the program.

Multidimensional Psychological Flexibility Inventory

Intervention Type DIAGNOSTIC_TEST

The assessment will be carried out at inclusion and after completion of the program.

satisfaction questionnaire and semi-structured interview

Intervention Type OTHER

The assessments will be carried out after completion of the program.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mindfulness closed program

MAEva program will be proposed with meditative practices and three different themes will be addressed (one theme per session): Meditation, Acceptance and Commitment to values.

Intervention Type OTHER

Quality of life evaluation

The assessment will be carried out at inclusion and after completion of the program.

Intervention Type DIAGNOSTIC_TEST

Perceived Stress Scale

The assessment will be carried out at inclusion and after completion of the program.

Intervention Type DIAGNOSTIC_TEST

Multidimensional Psychological Flexibility Inventory

The assessment will be carried out at inclusion and after completion of the program.

Intervention Type DIAGNOSTIC_TEST

satisfaction questionnaire and semi-structured interview

The assessments will be carried out after completion of the program.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant of legal age
* Willingness to participate in the program - voluntary registration
* Commitment to attend all 3 program sessions
* Schedule compatible with participation in the 3 program sessions
* Participant has understood, signed and dated the consent form
* Participant affiliated to the social security system

Exclusion Criteria

* No desire to participate in the program - non-registration
* Previous participation in MAEva program
* No commitment to participate in the 3 program sessions
* Agenda incompatible with the 3 program sessions
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut de Cancérologie de Lorraine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut de Cancerologie de Lorraine

Vandœuvre-lès-Nancy, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A02765-42

Identifier Type: -

Identifier Source: org_study_id